statistiche ricercatore

RIVA, CRISTINA

Distribuzione geografica

Continente	#
NA - Nord America	8.442
EU - Europa	4.866
AS - Asia	3.049
SA - Sud America	360
Continente sconosciuto - Info sul continente non disponibili	82
AF - Africa	40
OC - Oceania	4
Totale	16.843

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	8.315
IT - Italia	2.311
SG - Singapore	1.003
UA - Ucraina	802
CN - Cina	686
VN - Vietnam	441
TR - Turchia	385
SE - Svezia	348
BR - Brasile	319
DE - Germania	311
HK - Hong Kong	307
FR - Francia	255
FI - Finlandia	249
IE - Irlanda	204
GB - Regno Unito	157
RU - Federazione Russa	112
CA - Canada	72
IN - India	63
BD - Bangladesh	51
JP - Giappone	31
NL - Olanda	26
MX - Messico	22
BE - Belgio	20
PL - Polonia	18
AR - Argentina	13
EU - Europa	13
ZA - Sudafrica	13
IQ - Iraq	12
SA - Arabia Saudita	9
GT - Guatemala	8
PK - Pakistan	8
CO - Colombia	7
ES - Italia	7
PH - Filippine	7
AT - Austria	6
CH - Svizzera	6
HN - Honduras	6
LT - Lituania	6
UZ - Uzbekistan	6
ID - Indonesia	5
JO - Giordania	5
KE - Kenya	5
AE - Emirati Arabi Uniti	4
DK - Danimarca	4
EC - Ecuador	4
EG - Egitto	4
MA - Marocco	4
OM - Oman	4
PE - Perù	4
TN - Tunisia	4
AU - Australia	3
BB - Barbados	3
BO - Bolivia	3
CZ - Repubblica Ceca	3
ET - Etiopia	3
HR - Croazia	3
HU - Ungheria	3
LB - Libano	3
NP - Nepal	3
PY - Paraguay	3
SK - Slovacchia (Repubblica Slovacca)	3
SV - El Salvador	3
AM - Armenia	2
CR - Costa Rica	2
CW - ???statistics.table.value.countryCode.CW???	2
GE - Georgia	2
LU - Lussemburgo	2
MD - Moldavia	2
MY - Malesia	2
NG - Nigeria	2
NI - Nicaragua	2
PA - Panama	2
PR - Porto Rico	2
SN - Senegal	2
UY - Uruguay	2
VE - Venezuela	2
AF - Afghanistan, Repubblica islamica di	1
AL - Albania	1
AZ - Azerbaigian	1
CL - Cile	1
DM - Dominica	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
GP - Guadalupe	1
GR - Grecia	1
GY - Guiana	1
IS - Islanda	1
JM - Giamaica	1
KR - Corea	1
LV - Lettonia	1
MO - Macao, regione amministrativa speciale della Cina	1
MT - Malta	1
MV - Maldive	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PS - Palestinian Territory	1
PT - Portogallo	1
QA - Qatar	1
RO - Romania	1
RW - Ruanda	1
Totale	16.770

Salva come PNG Salva come JPEG

Città	#
Milan	1.574
Ashburn	1.044
San Jose	741
Jacksonville	609
Chandler	586
Fairfield	578
Singapore	518
Woodbridge	388
Dearborn	317
Hong Kong	303
Council Bluffs	290
Ann Arbor	280
Houston	259
Wilmington	251
Princeton	216
Beijing	206
Seattle	204
Dublin	202
Izmir	190
Nyköping	183
Cambridge	171
Dallas	147
Boardman	127
Rome	124
The Dalles	116
Dong Ket	110
New York	105
Los Angeles	96
Lauterbourg	93
Chicago	90
San Mateo	88
Ho Chi Minh City	75
Como	71
São Paulo	66
Munich	53
San Diego	51
Hanoi	47
Orem	42
Ogden	41
Santa Clara	41
Helsinki	40
Buffalo	37
Toronto	32
Guangzhou	29
Hefei	29
Tokyo	29
Chennai	24
London	23
Kunming	20
Nanjing	18
Turku	18
Brussels	17
Manchester	17
Atlanta	16
Denver	16
Phoenix	16
Warsaw	16
Jinan	15
Verona	15
Brooklyn	14
Poplar	14
San Francisco	14
Norwalk	13
Washington	13
Amsterdam	12
Da Nang	12
Düsseldorf	12
Montreal	12
Nanchang	12
Boston	10
Frankfurt am Main	10
Hangzhou	10
Rio de Janeiro	10
Catania	9
Mexico City	9
New Delhi	9
Ankara	8
Haiphong	8
Johannesburg	8
Naples	8
Pune	8
Salt Lake City	8
Casorezzo	7
Changsha	7
Fuzhou	7
Shenyang	7
Stockholm	7
Tianjin	7
Auburn Hills	6
Baghdad	6
Biên Hòa	6
Campinas	6
Florence	6
Guatemala City	6
Miami	6
Nuremberg	6
Redwood City	6
Shanghai	6
Vienna	6
Amman	5
Totale	11.476

Salva come PNG Salva come JPEG

Nome	#
Loss of function of Ribonuclease T2, an ancient and phylogenetically conserved RNase, plays a crucial role in ovarian tumorigenesis	328
LUTEOMA GRAVIDICO CON ASCITE MASSIVA: DESCRIZIONE DI UN CASO	293
Microsatellite analysis of sporadic and hereditary gynaecological cancer in routine diagnostics	269
Durable recurrence-free survival after pneumonectomy for late lung metastasis from rectal cancer: Case report with genetic and epigenetic analyses	255
Carcinosarcoma of the uterine cervix: Case report and discussion.	250
Inherited cancer syndromes in 220 Italian ovarian cancer patients	244
A cell-autonomous oncosuppressive role of human RNASET2 affecting ECM-mediated oncogenic signaling	243
Somatic Testing on Gynecological Cancers Improve the Identification of Lynch Syndrome	242
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase.	235
Biochemical and immunohistochemical characterization of human RNASET2 expression	227
Natural history of cervical intraepithelial neoplasia during pregnancy.	223
Two Cases of Carcinosarcomas of the Ovary Involved in Hereditary Cancer Syndromes	220
Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers	219
Tumor suppression by means of microenvironment-mediated stress response: the role of the human RNASET2 gene	219
Primary Extranodal Marginal Cell Lymphoma, MALT Type, of the Endometrium Arising in a Patient With Rheumatoid Arthritis: Report of a Case	216
Oxidative DNA damage induces hypomethylation in a compromised base excision repair colorectal tumourigenesis	213
Endometrial cancer cells can express fibrinogen: Immunohistochemistry and RT-PCR analysis	212
Tumor antagonizing genes and ovarian cancer: the role of the human RNASET2 gene.	205
Renal cell carcinoma metastatic to a pituitary FSH/LH adenoma: Case report and review of the literature	204
Genetic and cytogenetic observations among different types of ovarian tumors are compatible with a progression model underlying ovarian tumorigenesis	203
Intraoperative radioimmunoguided of colo-rectal cancer using monoclonal antibody B72.3 labelled with 125I	197
RNASET2 expression in ovarian epithelial tumors and clinico-pathological correlations.	196
Primary peritoneal cancer in Lynch syndrome: a clinical-pathologic report of a case and analysis of the literature.	189
Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences	187
Identifying factors contributing to reduced breast tumor size: A longitudinal study	185
"Proximal type" epithelioid sarcoma of the vulva: differential diagnosis with other extrarenal rhabdoid tumors	182
Early Involvement of 6q in Surface Epithelial Ovarian Tumors	182
RNASET2, a human tumor antagonizing gene supressing tumor growth in vivo but not in vitro	178
Calretinin expression in different molecular subtypes of ER and PR negative breast carcinomas	177
Risk factors for cervical intraepithelial neoplasia recurrence after conization: a 10-year study	177
CD44 expression in ER and PR negative ductal breast carcinomas	171
Breast carcinomas with neuroendocrine features are neoplasms of low grade malignancy	171
Physical map of the D6S149-D6S193 region on chromosome 6Q27 and its involement in benign surface epithelial ovarian tumours	170
Targeted gene sequencing of Lynch syndrome–related and sporadic endometrial carcinomas	167
Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer.	167
Human RNASET2 mediates tumor suppression by means of in vivo recruitment of stromal cells	166
Fetoplacental cytomegalovirus infection. A case report	165
Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms	162
Chromosome 6 abnormalities in borderline ovarian tumours suggest a genetic continuum in the progression model of ovarian neoplasms.	162
6q27 contains candidate genes involved in surface epithelial ovarian tumors. 4th congress of the European Society for Gynecologic and Obstetric Investigation, Madonna di Campiglio, 14-20 marzo, 1999	159
Adenohypophyseal differentiation in ovarian mature cystic teratomas and in ovarian carcinoids	159
Ovarian metastases from colorectal carcinoma. Clinicopathologic profile, immunophenotype, and karyotype analysis	158
IDENTIFICAZIONE E TIPIZZAZIONE DEI GENOTIPI HPV AD ALTO RISCHIO NELLE LESIONI PRENEOPLASTICHE DELLA CERVICE UTERINA: CORRELAZIONI CLINICOPATOLOGICHE	158
Disorders of the Endocrine System	158
Prognostic significance of p53, CA19.9 and M3SI expression in ovarian carcinomas	156
Non-chromaffin paraganglioma of the cervix uteri. Immunohistochemical and ultrastructural study	155
Diabetic fibrous mastopathy: sonographic-pathologic correlation	154
RNASET2 is a non-cell autonomous human tumor suppressor	152
Prevalence of HIV-1 primary drug resistance in seroconverters of the ICoNA cohort over the period 1996-2001	151
The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.	151
Aspetti clinico-patologici dei teratomi maturi cistici dell’ovaio e caratterizzazione delle componenti endocrine	150
The in vivo tumor antagonizing role of human RNASET2 is mediated by host stromal cells recruitment	150
Clinico-pathological correlations of karyotype analysis in ovarian carcinomas	149
Instabilità dei microsatelliti e perdita dell’espressione della proteina hMLH1 in carcinomi sincroni endometriali e ovarici	148
Microsatellite instability in endometrial cancer. Relation to histological subtypes	146
Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma.	146
IMMUNOPHENOTYPIC EVALUATION OF ESTROGEN AND PROGESTERONE RECEPTORS NEGATIVE BREAST CARCINOMAS	146
Espressione del recettore degli androgeni nel carcinoma mammario	145
Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts	145
Capitolo 9.7: Intestino tenue	143
Carcinoma lobulare in situ e invasivo: studio di clonalità con mtDNA	142
Prognostic significance of karyotype analysis in ovarian carcinomas	142
Prognostic significance of p53, CA19.9 and M3SI expression in ovarian carcinomas	141
Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells.Neoplasia	141
Androgen receptors in breast	141
Clinicopathological features of oral carcinoma: analysis of 240 cases	140
IL CARCINOMA MICROINVASIVO DELLA CERVICE	139
Ovarian retiform Sertoli-Leydig cell tumor : clinicopathological study of a case, 22th Int Meeting of the Adriatic Society of Pathology	136
Immunohistochemical expression and methilation status of MGMT in diffuse large B-cells lymphomas	134
METILAZIONE DE NOVO DI p16, hMLH1 E MGMT NEI CARCINOMI SINCRONI ENDOMETRIALI E OVARICI	132
LONG-TERM FOLLOW-UP OF IN SITU CARCINOMA OF THE BREAST	128
Histopathology, hormone products, and clinico-pathologic profile of endocrine tumors of the small intestine. A study of 44 cases.	128
Chromosome 6 abnormalities in borderline tumors suggest a genetic continuum in the progression model of ovarian neoplasms	126
Pituitary adenomas, a thirty-four-years experience in a –single institution.	126
“Microsatellite instability and lack of hMLH1 expression in synchronous endometrial and ovarian carcinomas”	125
Rnaset2, the first human ribonuclease of the rh/t2/s family, displays a role in tumor suppression	124
Chromosome 6 abnormalities are frequently expressed in Borderline Ovarian Epithelial Tumors suggesting a progression model of ovarian carcinogenesis	122
Prognostic significance of p53 CA 19-9 and M3SI expression in ovarian carcinomas.	121
ESTROGEN RECEPTOR NEGATIVE INVASIVE BREAST CARCINOMAS FREQUENTLY EXPRESS MYOEPITHELIAL MARKERS	120
Ki67, p53 and pttg-1 expression in invasive pituitary adenomas.	120
Microsatellite instability and lack of hMLH1 expression in syncronous endometrial and ovarian carcinomas	120
Capitolo 9.6: Stomaco	120
Correlation between microsatellite instability, clinico-pathological and immunohistochemical features in endometrial carcinomas	118
Instabilità dei microsatelliti e perdita dell'espressione della proteina hMLH1 in carcinomi sincroni endometriali e ovarici	118
PLACENTAL MALARIA AS A CAUSE OF INTRPAUTERINE FETAL DEATH IN ASYMPTOMATIC PATIENT. A CASE REPORT	115
The applications of FISH in tumor pathology	114
Frequency and chacterization of anterior pituitary component in ovarian mature cystic teratomas.	112
Er negative, p53 positive, breast cancers frequently express basal and myoepithelial cell markers	111
Clinico - Pathological profile of Estrogen and Progesteron receptors negatibe breast cancinomas with basal or luminal markers expression	110
p53 positive, breast cancers frequently express basal and myoepithelial cell markers	107
Microsatellite instability and lack of hMLH1 expression in synchronous endometrial and ovarian carcinomas	107
Ovarian metastases: clinico-pathological profile, immunophenotype and Karyotype analysis	106
Gestione per processi in anatomia patologica. Strumenti di analisi del rischio di errore. Azioni correttive e di miglioramento	106
Prognostic significance of karyotype analysis in ovarian carcinomas	104
Molecular genetics of syncronous endometrial and ovarian carcinomas	104
Expression of gastrointestinal markers in pancreatic carcinomas	104
Ano	104
Classification and histogenesis of gastroenteropancreatic endocrine tumors.	103
Correlazioni cisto-isto-colposcopiche in 150 casi consecutivi di patologia cervicale.	103
CLINICO-PATHOLOGICAL PROFILE OF ESTROGEN AND PROGESTERONE NEGATIVE BREAST CARCINOMAS WITH BASAL OR LUMINAL MARKERS EXPRESSION	102
Totale	16.066

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	64.214
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	64.214

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	726	0	0	0	76	46	37	37	69	53	161	83	164
2022/2023	1.460	127	99	105	195	91	299	3	201	219	35	59	27
2023/2024	2.348	394	388	400	413	470	149	9	17	57	16	17	18
2024/2025	1.448	9	21	264	41	49	59	50	81	214	113	137	410
2025/2026	3.566	263	221	121	569	361	222	717	201	392	249	141	109
2026/2027	1.517	114	185	580	638	0	0	0	0	0	0	0	0
Totale													16.843